|
|
|
Insider
Information: |
Luo Mary Z. |
Relationship: |
COO,Chief Scientist & ... |
City: |
Rancho Cucamonga |
State: |
CA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
1 |
|
Direct
Shares |
2,433,554 |
|
Indirect Shares
|
8,057,435 |
|
|
Direct
Value |
$102,744,650 |
|
|
Indirect Value
|
$340,184,906 |
|
|
Total
Shares |
10,490,989 |
|
|
Total
Value |
$442,929,556 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
0
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Amphastar Pharmaceuticals, Inc. |
AMPH |
COO,Chief Scientist & ... |
2024-03-17 |
2,433,554 |
2024-03-17 |
8,057,435 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
170 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 4 of 7
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
AMPH |
Amphastar Pharmaceuticals... |
COO, Chief Scientist, Chairman |
|
2016-03-17 |
4 |
A |
$0.00 |
$0 |
D/D |
184,466 |
1,129,902 |
0 |
- |
|
AMPH |
Amphastar Pharmaceuticals... |
COO, Chief Scientist, Chairman |
|
2024-03-04 |
4 |
A |
$0.00 |
$0 |
I/I |
27,110 |
1,131,526 |
0 |
- |
|
AMPH |
Amphastar Pharmaceuticals... |
COO Chief Scientist & Chairman |
|
2016-09-21 |
4 |
OE |
$16.75 |
$922,772 |
D/D |
55,081 |
1,143,416 |
0 |
- |
|
AMPH |
Amphastar Pharmaceuticals... |
COO, Chief Scientist Chairman |
|
2017-03-27 |
4 |
D |
$14.27 |
$392,140 |
D/D |
(27,480) |
1,172,502 |
0 |
- |
|
AMPH |
Amphastar Pharmaceuticals... |
COO,Chief Scientist & Chairman |
|
2017-09-13 |
4 |
OE |
$11.53 |
$1,598,427 |
I/I |
138,632 |
1,197,337 |
0 |
- |
|
AMPH |
Amphastar Pharmaceuticals... |
COO, Chief Scientist Chairman |
|
2017-03-26 |
4 |
D |
$13.76 |
$299,954 |
D/D |
(21,799) |
1,199,982 |
0 |
- |
|
AMPH |
Amphastar Pharmaceuticals... |
COO, Chief Scientist, Chairman |
|
2017-03-17 |
4 |
D |
$13.75 |
$317,735 |
D/D |
(23,108) |
1,221,781 |
0 |
- |
|
AMPH |
Amphastar Pharmaceuticals... |
COO,Chief Scientist & Chairman |
|
2024-03-17 |
4 |
D |
$43.05 |
$303,589 |
I/I |
(7,052) |
1,229,756 |
0 |
- |
|
AMPH |
Amphastar Pharmaceuticals... |
COO,Chief Scientist & Chairman |
|
2024-03-15 |
4 |
D |
$43.05 |
$8,724,427 |
I/I |
(202,658) |
1,236,808 |
0 |
- |
|
AMPH |
Amphastar Pharmaceuticals... |
COO, Chief Scientist, Chairman |
|
2017-03-16 |
4 |
A |
$0.00 |
$0 |
D/D |
156,554 |
1,244,889 |
0 |
- |
|
AMPH |
Amphastar Pharmaceuticals... |
COO,Chief Scientist & Chairman |
|
2017-11-13 |
4 |
OE |
$12.02 |
$2,242,831 |
I/I |
186,545 |
1,263,378 |
0 |
- |
|
AMPH |
Amphastar Pharmaceuticals... |
COO Chief Scientist & Chairman |
|
2016-09-20 |
4 |
OE |
$16.75 |
$3,473,735 |
D/D |
207,350 |
1,295,685 |
0 |
- |
|
AMPH |
Amphastar Pharmaceuticals... |
COO, Chief Scientist/Chairman |
|
2017-12-15 |
4 |
D |
$19.30 |
$5,902,384 |
I/I |
(305,823) |
1,330,646 |
0 |
- |
|
AMPH |
Amphastar Pharmaceuticals... |
COO Chief Scientist & Chairman |
|
2018-03-26 |
4 |
D |
$18.61 |
$164,587 |
I/I |
(8,844) |
1,346,129 |
0 |
- |
|
AMPH |
Amphastar Pharmaceuticals... |
COO, Chief Scientist, Chairman |
|
2018-03-17 |
4 |
D |
$19.91 |
$190,917 |
I/I |
(9,589) |
1,354,973 |
0 |
- |
|
AMPH |
Amphastar Pharmaceuticals... |
COO, Chief Scientist, Chairman |
|
2018-03-16 |
4 |
D |
$19.91 |
$154,721 |
I/I |
(7,771) |
1,364,562 |
0 |
- |
|
AMPH |
Amphastar Pharmaceuticals... |
COO,Chief Scientist & Chairman |
|
2018-07-02 |
4 |
D |
$15.39 |
$2,554,248 |
I/I |
(165,968) |
1,366,706 |
0 |
- |
|
AMPH |
Amphastar Pharmaceuticals... |
COO, Chief Scientist, Chairman |
|
2018-03-15 |
4 |
A |
$0.00 |
$0 |
I/I |
41,687 |
1,372,333 |
0 |
- |
|
AMPH |
Amphastar Pharmaceuticals... |
COO,Chief Scientist & Chairman |
|
2020-03-16 |
4 |
D |
$13.03 |
$101,256 |
I/I |
(7,771) |
1,381,658 |
0 |
- |
|
AMPH |
Amphastar Pharmaceuticals... |
COO,Chief Scientist & Chairman |
|
2020-03-15 |
4 |
D |
$14.19 |
$136,125 |
I/I |
(9,593) |
1,389,429 |
0 |
- |
|
AMPH |
Amphastar Pharmaceuticals... |
COO Chief Scientist & Chairman |
|
2019-03-17 |
4 |
D |
$20.23 |
$282,026 |
I/I |
(13,941) |
1,399,022 |
0 |
- |
|
AMPH |
Amphastar Pharmaceuticals... |
COO Chief Scientist & Chairman |
|
2019-03-16 |
4 |
D |
$20.23 |
$239,361 |
I/I |
(11,832) |
1,412,963 |
0 |
- |
|
AMPH |
Amphastar Pharmaceuticals... |
COO Chief Scientist & Chairman |
|
2019-03-15 |
4 |
D |
$20.23 |
$4,211,279 |
I/I |
(208,170) |
1,424,795 |
0 |
- |
|
AMPH |
Amphastar Pharmaceuticals... |
COO,Chief Scientist & Chairman |
|
2021-03-16 |
4 |
D |
$18.44 |
$163,932 |
I/I |
(8,890) |
1,431,479 |
0 |
- |
|
AMPH |
Amphastar Pharmaceuticals... |
COO Chief Scientist & Chairman |
|
2019-03-15 |
4 |
A |
$0.00 |
$0 |
I/I |
41,522 |
1,432,112 |
0 |
- |
|
170 Records found
|
|
Page 4 of 7 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|